Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

CV Sciences (CVSI) Non-Current Deffered Revenue (2017 - 2020)

CV Sciences (CVSI) has disclosed Non-Current Deffered Revenue for 3 consecutive years, with $1.5 million as the latest value for Q4 2020.

  • Quarterly Non-Current Deffered Revenue changed N/A to $1.5 million in Q4 2020 from the year-ago period, while the trailing twelve-month figure was $1.5 million through Dec 2020, changed N/A year-over-year, with the annual reading at $1.5 million for FY2020, N/A changed from the prior year.
  • Non-Current Deffered Revenue hit $1.5 million in Q4 2020 for CV Sciences, up from $1.3 million in the prior quarter.
  • In the past five years, Non-Current Deffered Revenue ranged from a high of $1.5 million in Q4 2020 to a low of $1.1 million in Q4 2017.
  • Historically, Non-Current Deffered Revenue has averaged $1.3 million across 3 years, with a median of $1.3 million in 2018.
  • Biggest YoY gain for Non-Current Deffered Revenue was 24.44% in 2018; the steepest drop was 24.44% in 2018.
  • Year by year, Non-Current Deffered Revenue stood at $1.1 million in 2017, then rose by 24.44% to $1.3 million in 2018, then increased by 9.33% to $1.5 million in 2020.
  • Business Quant data shows Non-Current Deffered Revenue for CVSI at $1.5 million in Q4 2020, $1.3 million in Q4 2018, and $1.1 million in Q4 2017.